$9.76 0.00 (0%)
10/12/2010 3:59 PM

ZymoGenetics, Inc. (NASDAQ:ZGEN)

CAPS Rating: 3 out of 5

The Company is focused on the discovery, development, manufacture and commercialization of therapeutic proteins for the treatment of human diseases.

Featured Broker Partners


Advertisement